Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state

Human Brain Mapping

Volumn 18, Issue 2, 2003, Pages 135-145

  Abel, Kathryn M ^a   Allin, Matthew P G ^a   Kucharska Pietura, Katarzyna ^b   Andrew, Chris ^a   Williams, Steve ^a   David, Anthony S ^a   Phillips, Mary L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cerebral circulation; Glutamate; Neuroimaging; NMDA receptors; Psychopharmacology

Indexed keywords

GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ACCURACY; ADULT; ARTICLE; BRAIN BLOOD FLOW; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; COGNITION; CONTRAST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FACE; GENDER; HUMAN; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIGNAL PROCESSING; TASK PERFORMANCE; VISUAL DISCRIMINATION;

ADULT; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; COGNITION; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; REFERENCE VALUES;

EID: 0037305099     PISSN: 10659471     EISSN: None     Source Type: Journal    
DOI: 10.1002/hbm.10064     Document Type: Article

References (44)

1. Abel KM, Allin M, Geyer M (2000): Subanesthetic ketamine in healthy male volunteers: effects on sensorimotor gating, cognitive performance and perception. Schizophr Res 41:236.
2. Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A (1998): Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43:811-816.
3. Artru AA (1990): Hypocapnia or diazepam reverses, and midazolam or fentanyl attenuates ketamine induced increase of cerebral blood volume and/or CSF pressure. In: Domino EF, editor. Status of ketamine in anesthesiology. Ann Arbor: NPP Books.
4. Beart PM, Sheehan K-AM, Manallack DT (1988): Absence of N-methyl-D-aspartate receptors on ovine cerebral microvessels. J Cereb Blood Flow Metab 8:879-882.
5. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D (1997): Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry 154:805-811.
6. Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS, Mazure CM (1991): Measurement of dissociative states with the Clinician Administered Dissociative States Scale. J Trauma Stress 11:25-136.
7. Bullmore ET, Brammer MJ, Williams SCR, Rabe-Hesketh S, Janot N, David AS, Mellers JDC, Howard, R, Sham P (1996): Statistical methods of estimation and inference for functional MR image analysis. Magn Reson Med 35:261-277.
8. Bullmore ET, Brammer MJ, Rabe-Hesketh S, Curtis VA, Morris RG, Williams SCR, Sharma T, Murray RM, McGuire PK (1999a): Methods for the diagnosis and treatment of stimulus correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp 7:38-48.
9. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ (1999b): Global, voxel and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 18:32-42.
10. Burdett NG, Menon DK, Carpenter TA, Jones JG, Hall LD (1995): Visualization of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results. Magn Reson Imaging 13:549-553.
11. Cavazzuti M, Porro CA, Biral GP, Benassi C, Barbieri GC (1987): Ketamine effects on local cerebral blood flow and metabolism in the rat. J Cereb Blood Flow Metab 7:806-811.
12. Corssen G, Domino EF (1966): Dissociative anesthesia: further pharmacologic studies and first clinical experience with phencyclidine derivative CI-581. Anesth Analg 45:29-40.
13. Dawson B, Michenfelder JB, Theye RA (1971): Effects of ketamine on canine cerebral blood flow and metabolism: modification by prior administration of thiopental. Anesth Analg 50:443-445.
14. Faraci FM, Breese KR (1993): Nitric oxide mediates vasodilation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 72:476-480.
15. Fergus A, Lee KS (1997): Regulation of cerebral microvessels by glutamatergic mechanisms. Brain Res 553:75-83.
16. Fukuda S, Murakawa T, Takeshita H, Toda N (1983): Direct effects of ketamine on isolated canine cerebral and mesenteric arteries. Anesth Analg 62:533-558.
17. Golanov EV, Yamamoto S, Reis DJ (1994): Spontaneous waves of cerebral blood flow associated with a pattern of electrocortical activity. Am J Physiol 266:R204-R214.
18. Golanov EV, Reis DJ (1996): Cerebral cortical neurons with activity linked to central neurogenic spontaneous and evoked elevations in cerebral blood flow. Neurosci Lett 209:101-104.
19. Haxby JV, Ungerleider LG, Horwitz B, Maisog JM, Rappoport SI, Grady, CL (1996): Face encoding and recognition in the human brain. Proc Natl Acad Sci USA 93:922-927.
20. Hedlund JL, Vieweg BW (1980): The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. J Operation Psych 11:48-64.
21. Herrschaft H, Schmidt H (1973): Der Einflub von Ketaminauf die Hirndurchblutung beim Menshen. In: Gemperle M, Kreuscher H, Langrehr D, editor. Ketamin. Berlin: Springer-Verlag, p 187-208.
22. Hougaard K, Hansen A, Brodersen P (1974): The effect of ketamine on regional cerebral blood flow in man. Anesthesiology 41:562-567.
23. Jueptner M, Weiller C (1995): Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. Neuroimage 2:148-156.
24. Kreuscher H, Grote J (1967): Die Wirking des Phenylcyclidin-Derivatives Ketamine (CI581) auf die Durchbkutung und Saures-Stoffaufnahme des Gihirns bein Hund. Der Anesthetist 16:304-307.
25. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS (1994): Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Arch Gen Psychiatry 51:199-214.
26. Lewis SJ, Barres C, Jacob HJ, Ohta H, Brody MJ (1989): Cardiovascular effects of the N-methyl-D-aspartate receptor antagonist, MK-801 in conscious rats. Hypertension 13:759-765.
27. Lahti AC, Holcolmb HH, Medoff DR, Tamminga CA (1995): Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport 6:869-872.
28. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996): NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301-307.
29. Moretti RJ, Hassan SZ, Goodman LI, Meltzer HY (1984): Comparison of ketamine and thiopental in healthy volunteers: effects on mental status, mood, and personality. Anesth Analg 63:1087-1096.
30. Ogawa S, Lee TM, Kay AR, Tank DW (1990): Brain magnetic resonance imaging with contrast dependent blood oxygenation. Proc Natl Acad Sci USA 87:8868-8872.
31. Overall JE, Gorham DR (1962): The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812.
32. Pandit SK, Kothary SP, Kumar SM (1980): Low dose intravenous infusion technique with ketamine. Amnesic, analgesic and sedative effects in human volunteers. Anesthesia 35:669-675.
33. Phillips ML, Young AW, Senior C, Brammer M, Andrew C, Calder AJ, Bullmore ET, Perrett DI, Rowland D, Williams SC, Gray JA, David AS (1997): A specific neural substrate for perceiving facial expressions of disgust. Nature 389:495-498.
34. Phillips ML, Bullmore ET, Howard R, Woodruff PW, Wright IC, Williams SC, Simmons A, Andrew C, Brammer M, David AS (1998): Investigation of facial recognition memory and happy and sad facial expression perception: an fMRI study. Psychiatry Res 83:127-138.
35. Puce A, Truett A, Asgari M, Gore JC, McCarthy G (1996): Differential sensitivity of human visual cortex to faces, letter strings, and textures: a functional magnetic resonance imaging study. J Neurosci 16:5205-5215.
36. Schwedler M, Miletich DJ, Albrecht RF (1982): Cerebral blood flow and metabolism following ketamine administration. Can Anaesth Soc J 29:223-225.
37. Sierra M, Berrios GE (2000): The Cambridge Depersonalization Scale: a new instrument for the measurement of depersonalization. Psychiatry Res 93:153-164.
38. Simmons A. Moore E. Williams SC (1999): Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting. Magn Reson Med 41:1274-1278.
39. Takayasu M, Dacey RG (1989): Effects of inhibitory and excitatory amino acid neurotransmitters on isolated cerebral parenchymal arterioles. Brain Res 482:393-396.
40. Takeshita H, Okuda Y, Sari A (1972): The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology 36: 69-74.
41. Talairach J, Toumoux P (1988): Co-planar stereotactic atlas of the human brain. Stuttgart, Germany: Thieme Verlag.
42. van Berckel BNM, Oranje B, van Ree JM, Verbaten MN, Kahn RS (1998): The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology 137:271-281.
43. Vollenweider FX, Leenders KL, Scharfetter C, Antonini A (1997a): Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [-super(18)F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 7:9-24.
44. Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J (1997b): Differential psychopathology and patterns of cerebral glucose utilization produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7:25-38.